Cargando…
Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation
BACKGROUND: Current approaches to chemical screening, prioritization, and assessment are being reenvisioned, driven by innovations in chemical safety testing, new chemical regulations, and demand for information on human and environmental impacts of chemicals. To conceptualize these changes through...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Institute of Environmental Health Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671249/ https://www.ncbi.nlm.nih.gov/pubmed/26032647 http://dx.doi.org/10.1289/ehp.1408337 |
_version_ | 1782404379297447936 |
---|---|
author | Schwarzman, Megan R. Ackerman, Janet M. Dairkee, Shanaz H. Fenton, Suzanne E. Johnson, Dale Navarro, Kathleen M. Osborne, Gwendolyn Rudel, Ruthann A. Solomon, Gina M. Zeise, Lauren Janssen, Sarah |
author_facet | Schwarzman, Megan R. Ackerman, Janet M. Dairkee, Shanaz H. Fenton, Suzanne E. Johnson, Dale Navarro, Kathleen M. Osborne, Gwendolyn Rudel, Ruthann A. Solomon, Gina M. Zeise, Lauren Janssen, Sarah |
author_sort | Schwarzman, Megan R. |
collection | PubMed |
description | BACKGROUND: Current approaches to chemical screening, prioritization, and assessment are being reenvisioned, driven by innovations in chemical safety testing, new chemical regulations, and demand for information on human and environmental impacts of chemicals. To conceptualize these changes through the lens of a prevalent disease, the Breast Cancer and Chemicals Policy project convened an interdisciplinary expert panel to investigate methods for identifying chemicals that may increase breast cancer risk. METHODS: Based on a review of current evidence, the panel identified key biological processes whose perturbation may alter breast cancer risk. We identified corresponding assays to develop the Hazard Identification Approach for Breast Carcinogens (HIA-BC), a method for detecting chemicals that may raise breast cancer risk. Finally, we conducted a literature-based pilot test of the HIA-BC. RESULTS: The HIA-BC identifies assays capable of detecting alterations to biological processes relevant to breast cancer, including cellular and molecular events, tissue changes, and factors that alter susceptibility. In the pilot test of the HIA-BC, chemicals associated with breast cancer all demonstrated genotoxic or endocrine activity, but not necessarily both. Significant data gaps persist. CONCLUSIONS: This approach could inform the development of toxicity testing that targets mechanisms relevant to breast cancer, providing a basis for identifying safer chemicals. The study identified important end points not currently evaluated by federal testing programs, including altered mammary gland development, Her2 activation, progesterone receptor activity, prolactin effects, and aspects of estrogen receptor β activity. This approach could be extended to identify the biological processes and screening methods relevant for other common diseases. CITATION: Schwarzman MR, Ackerman JM, Dairkee SH, Fenton SE, Johnson D, Navarro KM, Osborne G, Rudel RA, Solomon GM, Zeise L, Janssen S. 2015. Screening for chemical contributions to breast cancer risk: a case study for chemical safety evaluation. Environ Health Perspect 123:1255–1264; http://dx.doi.org/10.1289/ehp.1408337 |
format | Online Article Text |
id | pubmed-4671249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | National Institute of Environmental Health Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-46712492015-12-16 Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation Schwarzman, Megan R. Ackerman, Janet M. Dairkee, Shanaz H. Fenton, Suzanne E. Johnson, Dale Navarro, Kathleen M. Osborne, Gwendolyn Rudel, Ruthann A. Solomon, Gina M. Zeise, Lauren Janssen, Sarah Environ Health Perspect Review BACKGROUND: Current approaches to chemical screening, prioritization, and assessment are being reenvisioned, driven by innovations in chemical safety testing, new chemical regulations, and demand for information on human and environmental impacts of chemicals. To conceptualize these changes through the lens of a prevalent disease, the Breast Cancer and Chemicals Policy project convened an interdisciplinary expert panel to investigate methods for identifying chemicals that may increase breast cancer risk. METHODS: Based on a review of current evidence, the panel identified key biological processes whose perturbation may alter breast cancer risk. We identified corresponding assays to develop the Hazard Identification Approach for Breast Carcinogens (HIA-BC), a method for detecting chemicals that may raise breast cancer risk. Finally, we conducted a literature-based pilot test of the HIA-BC. RESULTS: The HIA-BC identifies assays capable of detecting alterations to biological processes relevant to breast cancer, including cellular and molecular events, tissue changes, and factors that alter susceptibility. In the pilot test of the HIA-BC, chemicals associated with breast cancer all demonstrated genotoxic or endocrine activity, but not necessarily both. Significant data gaps persist. CONCLUSIONS: This approach could inform the development of toxicity testing that targets mechanisms relevant to breast cancer, providing a basis for identifying safer chemicals. The study identified important end points not currently evaluated by federal testing programs, including altered mammary gland development, Her2 activation, progesterone receptor activity, prolactin effects, and aspects of estrogen receptor β activity. This approach could be extended to identify the biological processes and screening methods relevant for other common diseases. CITATION: Schwarzman MR, Ackerman JM, Dairkee SH, Fenton SE, Johnson D, Navarro KM, Osborne G, Rudel RA, Solomon GM, Zeise L, Janssen S. 2015. Screening for chemical contributions to breast cancer risk: a case study for chemical safety evaluation. Environ Health Perspect 123:1255–1264; http://dx.doi.org/10.1289/ehp.1408337 National Institute of Environmental Health Sciences 2015-06-02 2015-12 /pmc/articles/PMC4671249/ /pubmed/26032647 http://dx.doi.org/10.1289/ehp.1408337 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, “Reproduced with permission from Environmental Health Perspectives”); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright. |
spellingShingle | Review Schwarzman, Megan R. Ackerman, Janet M. Dairkee, Shanaz H. Fenton, Suzanne E. Johnson, Dale Navarro, Kathleen M. Osborne, Gwendolyn Rudel, Ruthann A. Solomon, Gina M. Zeise, Lauren Janssen, Sarah Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title | Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title_full | Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title_fullStr | Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title_full_unstemmed | Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title_short | Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation |
title_sort | screening for chemical contributions to breast cancer risk: a case study for chemical safety evaluation |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671249/ https://www.ncbi.nlm.nih.gov/pubmed/26032647 http://dx.doi.org/10.1289/ehp.1408337 |
work_keys_str_mv | AT schwarzmanmeganr screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT ackermanjanetm screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT dairkeeshanazh screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT fentonsuzannee screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT johnsondale screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT navarrokathleenm screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT osbornegwendolyn screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT rudelruthanna screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT solomonginam screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT zeiselauren screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation AT janssensarah screeningforchemicalcontributionstobreastcancerriskacasestudyforchemicalsafetyevaluation |